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Background: Diabetes Mellitus (DM) is considered a risk equivalent for coronary artery disease (CAD) based upon similar outcomes in diabetic 
patients without CAD and non-diabetic patients with CAD. This concept has not been examined utilizing non-invasive imaging. The aim of the study 
was to compare cardiovascular (CV) outcomes and myocardial perfusion imaging (MPI) results in a large study population referred for stress SPECT-
MPI in diabetic patients with and without CAD.
Methodology: Follow-up data (cardiac death or non-fatal MI) from 15,295 consecutive patients who underwent stress SPECT MPI with a mean CV 
event follow-up of 2±1 SD years were prospectively collected. The cohort was subdivided into four categories: DM without CAD, DM with CAD, non-DM 
without CAD and non-DM with CAD. SPECT interpretation used the ASNC 17-segment model. The groups were divided into normal (Summed Stress 
Score (SSS)<4) and abnormal (SSS≥4). Annualized event rates were calculated and compared using multivariable Cox-Regression analyses.
Results: CV events occurred in 891 out of 15,295 patients (5.8%). After multivariate adjustment, the CV events in non-diabetic patients with CAD 
and diabetic patients without CAD were not significantly different for each SPECT category, Fig 1.
Conclusion: Diabetic patients without CAD have similar outcomes to non-diabetic patients with CAD, with and without perfusion abnormalities. 
Hence our study supports treating diabetics as “CAD risk equivalent” conforming to the ACC/AHA standards.
